Antigenically distinct conformations of CXCR4

Journal of Virology

Volumn 75, Issue 19, 2001, Pages 8957-8967

  Baribaud, F ^a   Edwards, T G ^a   Sharron, M ^a   Brelot, A ^a   Heveker, N ^a   Price, K ^a   Mortari, F ^a   Alizon, M ^a   Tsang, M ^a   Doms, R W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PERTUSSIS TOXIN; RECEPTOR ANTIBODY; STROMAL CELL DERIVED FACTOR 1; VIRUS RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; B LYMPHOCYTE; CELL TYPE; CHEMOTAXIS; CONTROLLED STUDY; EMBRYO; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; RECEPTOR AFFINITY; SULFATION; T LYMPHOCYTE; VIRUS INFECTION; VIRUS STRAIN;

AMINO ACID SEQUENCE; EPITOPES; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; RECEPTORS, CXCR4;

EID: 0034858033     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.19.8957-8967.2001     Document Type: Article

References (58)

1. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
2. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
3. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains
4. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
5. Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities
6. Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity
7. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical surface
8. N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates
9. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
10. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
11. HIV coreceptor use: A molecular window into viral tropism
12. HIV-1 membrane fusion: Targets of opportunity
13. The plasma membrane as a combat zone in the HIV battlefield
14. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
15. Safe use of the CXCR4-inhibitor AL40-4C in humans
16. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor
17. Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1
18. Identification of CXCR4 domains that support coreceptor and chemokine receptor functions
19. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry
20. A binding pocket for a small molecule inhibitor of HIV entry within the transmembrane helices of CCR5
21. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse HIV-1 and SIV envelope proteins
22. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4
23. Tyrosine sulfonation of the amino terminus of CCR5 facilitates HIV-1 entry
24. CCR5-Mediated human immunodeficiency virus entry depends on an amino-terminal gp120-binding site and on the conformational integrity of all four extracellular domains
25. HIV-1 envelope determinants for cell tropism and chemokine receptor use
26. SDF-1 responsiveness does not correlate with CXCR4 expression levels of developing human bone marrow B cells
27. G-protein diseases furnish a model for the turn-on switch
28. The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques
29. CD4, CXCR-4, and CCR5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1
30. Cooperation of multiple coreceptors for infections by human immunodeficiency virus type 1
31. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
32. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines
33. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function
34. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
35. HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation
36. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
37. Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent
38. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection
39. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7] Polyphemusin II): A possible inhibitor of virus-cell fusion
40. Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalization
41. Reduced HIV-1 infectability of CD4(+) lymphocytes from exposed-uninfected individuals: Association with low expression of CCR5 and high production of beta-chemokines
42. Effects of CCR5 and CD4 cell surface concentrations on infections by isolates of human immunodeficiency virus type 1
43. DC-SIGN interactions with human immunodeficiency virus type 1 and type 2 and simian immunodeficiency virus
44. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
45. Regions in β-chemokine receptors CKR-5 and CKR-2b that determine HIV-1 cofactor specificity
46. Resistance to HIV-1 infection of Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene
47. Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes
48. Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4
49. A monoclonal antibody (12G5) directed against CXCR-4 inhibits infection with the dual-tropic human immunodeficiency virus type 1 isolate HIV-I(HxB)
50. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium-inducing isolates in patients with acquired immuno-deficiency virus syndrome (AIDS) and AIDS-related complex
51. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency virus syndrome: Studies on sequential isolates
52. Signal transduction by CXC chemokine receptor 4: Stromal cell-derived factorl stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes
53. CD4-dependent, antibody-sensitive interactions between HIV-1 and its coreceptor CCR-5
54. The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus
55. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
56. Inefficient formation of a complex among CXCR4, CD4 and gp120 in U937 clones resistant to X4 gp120-gp41-mediated fusion
57. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic